Long-Term Effects of Rituximab Added to Cyclophosphamide in Refractory Patients with Vasculitis

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab in cryoglobulinemic peripheral neuropathy

(2009) Roberto Cavallo et al.   JOURNAL OF NEUROLOGY

The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)

(2009) A. J. Mohammad et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunotherapy for antineutrophil cytoplasmic antibody–associated vasculitis: challenging the therapeutic status quo?

(2008) Xavier Bosch et al.   TRENDS IN IMMUNOLOGY